Related Experiment Video
Updated: May 27, 2026

Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
Published on: November 11, 2014
Dnmt3a is essential for hematopoietic stem cell differentiation
Grant A Challen1, Deqiang Sun, Mira Jeong
1Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, Texas, USA.
Insights
Loss of DNA methyltransferase Dnmt3a impairs hematopoietic stem cell (HSC) differentiation and expands HSC numbers. Dnmt3a is critical for epigenetic silencing of HSC genes, enabling efficient differentiation.
Area of Science:
- Epigenetics
- Stem Cell Biology
- Hematopoiesis
Background:
- De novo DNA methyltransferases (Dnmt3a and Dnmt3b) are crucial for embryonic stem cell differentiation.
- The role of Dnmt3a and Dnmt3b in somatic stem cells, particularly hematopoietic stem cells (HSCs), remains largely unknown.
Purpose of the Study:
- To investigate the function of Dnmt3a in the maintenance and differentiation of HSCs.
Main Methods:
- Conditional ablation of Dnmt3a in HSCs.
- Serial transplantation assays to assess HSC function.
- DNA methylation analysis (CpG island methylation).
- Gene expression analysis of HSC multipotency and differentiation markers.
Main Results:
- Dnmt3a loss progressively impairs HSC differentiation and leads to an expansion of HSC numbers in the bone marrow.
- Dnmt3a-null HSCs exhibit altered DNA methylation patterns, including CpG island hypermethylation.
- Dnmt3a deficiency results in upregulation of HSC multipotency genes and downregulation of differentiation factors.
- Progeny of Dnmt3a-null HSCs show global hypomethylation and incomplete repression of HSC-specific genes.
Conclusions:
- Dnmt3a is essential for the epigenetic silencing of genes regulating HSC function.
- Dnmt3a plays a critical role in enabling efficient HSC differentiation by controlling gene expression through DNA methylation.
Abstract:
Loss of the de novo DNA methyltransferases Dnmt3a and Dnmt3b in embryonic stem cells obstructs differentiation; however, the role of these enzymes in somatic stem cells is largely unknown. Using conditional ablation, we show that Dnmt3a loss progressively impairs hematopoietic stem cell (HSC) differentiation over serial transplantation, while simultaneously expanding HSC numbers in the bone marrow. Dnmt3a-null HSCs show both increased and decreased methylation at distinct loci, including substantial CpG island hypermethylation. Dnmt3a-null HSCs upregulate HSC multipotency genes and downregulate differentiation factors, and their progeny exhibit global hypomethylation and incomplete repression of HSC-specific genes. These data establish Dnmt3a as a critical participant in the epigenetic silencing of HSC regulatory genes, thereby enabling efficient differentiation.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Hematopoiesis
Lineage Commitment
Multipotency of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Stem Cell Niche

